Abstract: The insulin-like growth factor (IGF) system regulates implantation, placental development, and angiogenesis in eutherian mammals. However, little is known about the changes in this system in equine placenta (chorioallantois; CA) and the endometrium (EN) during pregnancy, or the relationship to vascular endothelial growth factor () expression. The current study investigated the expression of the IGF system components, namely the ligands ( and ), their receptors (, , and ), and their binding proteins ( and s) in equine CA at 45 days, 4, 6, 10, and 11 months of gestational age (GA) and immediately postpartum (PP), and in equine EN at 4, 6, 10, and 11 months GA. IGF1 immunolocalization and serum concentrations were also evaluated across gestation. mRNA expression in CA increased from day 45 to peak at 6 months and then gradually declined to reach a nadir in PP samples. This profile correlated positively with the expression profile (r = 0.62, = 0.001). In contrast, expression in CA was not correlated with ( = 0.14). Interestingly, mRNA was more abundant in equine CA than ( < 0.05) throughout gestation. Among the IGFBPs investigated in CA, the expression of and was highly abundant ( < 0.05) at day 45 compared to other GAs. Conversely, mRNA expression for and was more abundant ( < 0.05) in PP than at all investigated GAs. Immunohistochemistry revealed that IGF1 is localized in the equine chorionic epithelium (cytoplasm and nucleus). IGF1 serum concentrations peaked at 9 months and declined to their lowest levels PP. In conclusion, this study demonstrates a positive correlation between and expression in equine CA during gestation, suggesting that the IGF system plays a crucial role in placental angiogenesis by regulating .
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This study examined how the components of the insulin-like growth factor (IGF) system change in the horse placenta and endometrium throughout pregnancy.
It explored the relationship between IGF system expression and vascular endothelial growth factor (VEGF), suggesting the IGF system’s important role in placental blood vessel formation during gestation.
Background and Significance
The IGF system includes growth factors IGF1 and IGF2, their receptors (IGF1R, IGF2R, insulin receptor – INSR), and binding proteins (IGFBPs).
This system is known to regulate key reproductive processes such as embryo implantation, placental development, and angiogenesis (formation of new blood vessels) in mammals.
Understanding IGF system dynamics in the equine placenta (chorioallantois, CA) and endometrium (EN) is important because little data existed prior on how this system changes with gestational age in horses.
VEGF is a well-known factor involved in placental blood vessel growth; investigating its relationship with IGF components provides insights into placental angiogenesis regulation.
Study Design and Methods
Sample collection:
Equine chorioallantois tissues collected at 45 days, 4 months, 6 months, 10 months, 11 months of gestation, and immediately postpartum (PP).
Equine endometrial tissues collected at 4, 6, 10, and 11 months of gestation.
Investigated molecular components:
IGF ligands: IGF1 and IGF2
Receptors: IGF1R, IGF2R, and INSR
Binding proteins: several IGFBPs, notably IGFBP1, IGFBP2, IGFBP4, and IGFBP5
Techniques used:
Quantitative mRNA expression analysis
Immunohistochemistry for protein localization of IGF1 within tissues
Measurement of IGF1 concentration in maternal serum throughout pregnancy
Correlation studies between IGF system components and VEGF (vascular endothelial growth factor) expression
Key Findings
IGF2 expression pattern in chorioallantois (CA):
mRNA expression increased from day 45 post-fertilization, peaked by 6 months gestation, then declined steadily until lowest levels immediately postpartum.
This expression profile positively correlated with the mRNA expression of VEGF (correlation coefficient r = 0.62, p = 0.001), supporting a link between IGF2 and placental angiogenesis.
IGF1 in chorioallantois:
IGF1 mRNA was consistently more abundant than IGF2 throughout gestation (statistically significant, p < 0.05).
IGF1 protein localized specifically in the chorionic epithelium cells’ cytoplasm and nucleus, indicating its functional relevance in this tissue.
Serum IGF1 concentrations peaked at 9 months gestation and fell to lowest levels after birth, indicating systemic regulation of IGF1 linked to pregnancy stage.
IGF receptors and binding proteins in the placenta:
The study highlights differential expression of receptors but focuses mainly on IGFBPs.
IGFBP1 and IGFBP2 had high expression at early gestation (day 45), suggesting a role in early placental development or implantation.
IGFBP4 and IGFBP5 mRNA levels were significantly higher postpartum than at any gestational age examined, implying roles perhaps in placental regression or remodeling after birth.
Correlation of IGF system components with VEGF:
Positive correlation between IGF2 and VEGF expression suggests IGF2’s involvement in stimulating placental blood vessel formation.
No significant correlation between IGF1 and VEGF, indicating different regulatory roles for the two IGFs.
Conclusions and Implications
The IGF system in the equine placenta changes dynamically throughout pregnancy, with distinct patterns for IGF1, IGF2, binding proteins, and receptors.
IGF2 expression closely links to VEGF, indicating that IGF2 likely supports placental angiogenesis in horses.
IGF1’s localization and serum profile suggest it also plays important but potentially different roles in pregnancy maintenance and fetal development.
These insights improve understanding of equine placental biology, which could have implications for managing equine pregnancy health and diagnosing gestational disorders.
The study provides a foundation for future research on therapeutic targets related to placental growth and function in horses and potentially other mammals.
Cite This Article
APA
Scoggin KE, Adlan F, Fedorka CE, Rakha SI, Stout TAE, Troedsson MHT, Ali HE.
(2025).
Gestation-Stage Related Changes in the IGF System Components in the Equine Placenta.
Biomolecules, 15(8), 1135.
https://doi.org/10.3390/biom15081135
Huang Z., Huang S., Song T., Yin Y., Tan C.. Placental Angiogenesis in Mammals: A Review of the Regulatory Effects of Signaling Pathways and Functional Nutrients.. Adv. Nutr. 2021;12:2415–2434.
Guzeloglu-Kayisli O., Kayisli U.A., Taylor H.S.. The role of growth factors and cytokines during implantation: Endocrine and paracrine interactions.. Semin. Reprod. Med. 2009;27:62–79.
Sarfstein R., Werner H.. The INSR/IGF1R Receptor Family.. In: Wheeler D.L., Yarden Y., editors. Receptor Tyrosine Kinases: Family and Subfamilies. Springer International Publishing; Cham, Switzerland: 2015. pp. 297–320.
MacDonald R.G., Pfeffer S.R., Coussens L., Tepper M.A., Brocklebank C.M., Mole J.E., Anderson J.K., Chen E., Czech M.P., Ullrich A.. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate.. Science. 1988;239:1134–1137.
Skogstrand K. Multiplex assays of inflammatory markers, a description of methods and discussion of precautions—Our experience through the last ten years.. Methods 2012;56:204–212.
Conesa A, Madrigal P, Tarazona S, Gomez-Cabrero D, Cervera A, McPherson A, Szczesniak MW, Gaffney DJ, Elo LL, Zhang X. A survey of best practices for RNA-seq data analysis.. Genome Biol. 2016;17:13.
Scoggin KE, Valet C, Stout TAE, Troedsson MHT, El-Sheikh Ali H. Expression of Placental Growth Factor and Vascular Endothelial Growth Factor Family in Equine Placenta Throughout Gestation.. Department of Veterinary Science, University of Kentucky, Lexington, KY, USA 2025.
Hiden U, Glitzner E, Hartmann M, Desoye G. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies.. J. Anat. 2009;215:60–68.
Pandey Y, Pooja AR, Devi HL, Jalmeria NS, Punetha M, Kumar S, Paul A, Kumar K, Sonawane A, Samad HA. Expression and functional role of IGFs during early pregnancy in placenta of water buffalo.. Theriogenology 2021;161:313–331.
Osgerby JC, Gadd TS, Wathes DC. Expression of insulin-like growth factor binding protein-1 (IGFBP-1) mRNA in the ovine uterus throughout the oestrous cycle and early pregnancy.. J. Endocrinol. 1999;162:279–287.
Miese-Looy G, MJ VDH, Edwards AK, Lamarre J, Tayade C. Expression of insulin-like growth factor (IGF) family members in porcine pregnancy.. J. Reprod. Dev. 2012;58:51–60.
Han VK, Carter AM. Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals.. Placenta 2000;21:289–305.
Boucher J, Charalambous M, Zarse K, Mori MA, Kleinridders A, Ristow M, Ferguson-Smith AC, Kahn CR. Insulin and insulin-like growth factor 1 receptors are required for normal expression of imprinted genes.. Proc. Natl. Acad. Sci. USA 2014;111:14512–14517.
Lambertini L, Marsit CJ, Sharma P, Maccani M, Ma Y, Hu J, Chen J. Imprinted gene expression in fetal growth and development.. Placenta 2012;33:480–486.
Moore GE, Ishida M, Demetriou C, Al-Olabi L, Leon LJ, Thomas AC, Abu-Amero S, Frost JM, Stafford JL, Chaoqun Y. The role and interaction of imprinted genes in human fetal growth.. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2015;370:20140074.
Kaczmarek MM, Blitek A, Kaminska K, Bodek G, Zygmunt M, Schams D, Ziecik AJ. Assessment of VEGF-receptor system expression in the porcine endometrial stromal cells in response to insulin-like growth factor-I, relaxin, oxytocin and prostaglandin E2.. Mol. Cell Endocrinol. 2008;291:33–41.
Yang H, Lee HH, Lee HC, Ko DS, Kim SS. Assessment of vascular endothelial growth factor expression and apoptosis in the ovarian graft: Can exogenous gonadotropin promote angiogenesis after ovarian transplantation?. Fertil. Steril. 2008;90:1550–1558.
Troja W, Kil K, Klanke C, Jones HN. Interaction between human placental microvascular endothelial cells and a model of human trophoblasts: Effects on growth cycle and angiogenic profile.. Physiol. Rep. 2014;2:e00244.
Angiolini E, Fowden A, Coan P, Sandovici I, Smith P, Dean W, Burton G, Tycko B, Reik W, Sibley C. Regulation of placental efficiency for nutrient transport by imprinted genes.. Placenta 2006;27((Suppl. A)):S98–S102.
Roy PK, Qamar AY, Tanga BM, Bang S, Seong G, Fang X, Kim G, Edirisinghe SL, De Zoysa M, Kang DH. Modified Spirulina maxima Pectin Nanoparticles Improve the Developmental Competence of In Vitro Matured Porcine Oocytes.. Animals 2021;11:2483.
Poreba E, Durzynska J. Nuclear localization and actions of the insulin-like growth factor 1 (IGF-1) system components: Transcriptional regulation and DNA damage response.. Mutat. Res. Rev. Mutat. Res. 2020;784:108307.
Xiu M, Huan X, Ou Y, Ying S, Wang J. The basic route of nuclear-targeted transport of IGF-1/IGF-1R and potential biological functions in intestinal epithelial cells.. Cell Prolif. 2021;54:e13030.
Chen H, Li Y, Shi J, Song W. Role and mechanism of insulin-like growth factor 2 on the proliferation of human trophoblasts in vitro.. J. Obstet. Gynaecol. Res. 2016;42:44–51.
Coan PM, Fowden AL, Constancia M, Ferguson-Smith AC, Burton GJ, Sibley CP. Disproportional effects of Igf2 knockout on placental morphology and diffusional exchange characteristics in the mouse.. J. Physiol. 2008;586:5023–5032.
Choi E, Duan C, Bai XC. Regulation and function of insulin and insulin-like growth factor receptor signalling.. Nat. Rev. Mol. Cell Biol. 2025;26:558–580.
Han VK, Bassett N, Walton J, Challis JR. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: Evidence for IGF-IGFBP interactions at the feto-maternal interface.. J. Clin. Endocrinol. Metab. 1996;81:2680–2693.
Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality.. Genes. Dev. 1994;8:2953–2963.
Daza DO, Sundström G, Bergqvist CA, Duan C, Larhammar D. Evolution of the insulin-like growth factor binding protein (IGFBP) family.. Endocrinology 2011;152:2278–2289.
Hamilton GS, Lysiak JJ, Han VK, Lala PK. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1.. Exp. Cell Res. 1998;244:147–156.
Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: Regulation by TGF-beta, IGF-II, and IGFBP-1.. Exp. Cell Res. 1995;217:419–427.
Wu L, Song WY, Xie Y, Hu LL, Hou XM, Wang R, Gao Y, Zhang JN, Zhang L, Li WW. miR-181a-5p suppresses invasion and migration of HTR-8/SVneo cells by directly targeting IGF2BP2.. Cell Death Dis. 2018;9:16.
Reynolds TS, Stevenson KR, Wathes DC. Pregnancy-specific alterations in the expression of the insulin-like growth factor system during early placental development in the ewe.. Endocrinology 1997;138:886–897.
Rogers J, Wiltrout L, Nanu L, Fant ME. Developmentally regulated expression of IGF binding protein-3 (IGFBP-3) in human placental fibroblasts: Effect of exogenous IGFBP-3 on IGF-1 action.. Regul. Pept. 1996;61:189–195.
Gadd TS, Osgerby JC, Wathes DC. Regulation and localization of insulin-like growth factor binding protein-5 gene expression in the uterus and placenta of the cyclic and early pregnant ewe.. Biol. Reprod. 2000;62:1415–1421.
Nawathe AR, Christian M, Kim SH, Johnson M, Savvidou MD, Terzidou V. Insulin-like growth factor axis in pregnancies affected by fetal growth disorders.. Clin. Epigenetics. 2016;8:11.